You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《亞洲股市》日經及港韓股升1%-1.4%跑贏
美國8月Markit綜合產出指數初值由紀錄高連續第三個月回落至55.4(前值59.9)創八個月低遠差預期,投資者料聯儲局短期不會急於「收水」,加上輝瑞與BioNTech合作研發新冠疫苗正式獲美國當局批准全面使用,紓緩對美國近期確診病例激增憂慮,商品價格全面上揚,尤其是油價急彈逾半成結束七連跌,美股昨晚在銀行、工業、能源、科技及晶片板塊領航全面續升0.6%-1.55%,納指及標普三連漲續跑贏兼齊再創紀錄高。美股期貨全面續升不足0.2%。 亞太區股市全面向好,但除日經及韓股續升1%及1.4%,分別報27,777及3,133外,其餘升幅均少於1%,其中新加坡海峽時報指數回升0.6%報3,107。吉隆坡綜合指數兩連升後,今早微升不足1點報1,523。滬指及深成繼昨天回升約1.5%-2%後,今早高開不足0.2%,分別報3,482及14,558。 港股繼昨天由曾急彈逾600點或2.4%至25,458遇阻,收市僅彈1%結束兩連挫後,今早在小米(01810.HK)、比亞迪(01211.HK)、美團(03690.HK)、重磅股騰訊(00700.HK)、已九連跌屢尋底阿里巴巴(09988.HK),以及中績多賺1.5倍的藥明生物(02269.HK)依次高開2%-8%帶動高開319點或1.3%報25,428,最高見25,489遇壓,現報25,382,僅續升273點或1.1%。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account